ASX - By Stock
|
PER |
Re:
Ann: Becoming a substantial holder
|
|
bradleyr
|
11 |
2.9K |
3 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
11
|
2.9K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Intention to launch Share Purchase Plan
|
|
bradleyr
|
75 |
21K |
1 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
75
|
21K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Intention to launch Share Purchase Plan
|
|
bradleyr
|
75 |
21K |
4 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
75
|
21K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bradleyr
|
117 |
28K |
6 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
117
|
28K
|
6
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
bradleyr
|
33K |
16M |
1 |
17/12/21 |
17/12/21 |
Charts
|
33K
|
16M
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
bradleyr
|
33K |
16M |
4 |
17/12/21 |
17/12/21 |
Charts
|
33K
|
16M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Clinicaltrials.gov has CF33-hNIS-antiPDL1 for Triple Negative Breast Cancer trial listed
|
|
bradleyr
|
130 |
85K |
20 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
130
|
85K
|
20
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD
|
|
bradleyr
|
174 |
47K |
11 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
174
|
47K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
bradleyr
|
14K |
6.8M |
6 |
09/08/21 |
09/08/21 |
ASX - By Stock
|
14K
|
6.8M
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Type C Meeting for ATL1102 in DMD
|
|
bradleyr
|
87 |
33K |
21 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
87
|
33K
|
21
|
|
ASX - By Stock
|
PER |
Re:
Ann: Proposed issue of Securities - ANP
|
|
bradleyr
|
79 |
26K |
5 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
79
|
26K
|
5
|
|
Charts
|
PER |
overseas interest
|
|
bradleyr
|
1 |
507 |
5 |
18/12/20 |
18/12/20 |
Charts
|
1
|
507
|
5
|
|
ASX - By Stock
|
ZNO |
Re:
Ann: Zoono Group Company Update
|
|
bradleyr
|
116 |
39K |
3 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
116
|
39K
|
3
|
|
ASX - By Stock
|
ZNO |
Re:
Ann: Zoono Group Company Update
|
|
bradleyr
|
116 |
39K |
4 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
116
|
39K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to present at Several Upcoming Virtual Conferences
|
|
bradleyr
|
33 |
7.8K |
0 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
33
|
7.8K
|
0
|
|
ASX - By Stock
|
PER |
Re:
AGM
|
|
bradleyr
|
70 |
14K |
3 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
70
|
14K
|
3
|
|
ASX - By Stock
|
ZNO |
Re:
Ann: Latest Testing Confirms Zoono Efficacy and Longevity
|
|
bradleyr
|
67 |
15K |
8 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
67
|
15K
|
8
|
|
ASX - By Stock
|
ZNO |
Re:
Ann: Latest Testing Confirms Zoono Efficacy and Longevity
|
|
bradleyr
|
67 |
15K |
0 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
67
|
15K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP receives US FDA ODD for ATL1102 in DMD
|
|
bradleyr
|
23 |
8.1K |
5 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
23
|
8.1K
|
5
|
|
Charts
|
PER |
Re:
Chart
|
|
bradleyr
|
5.9K |
2.3M |
2 |
19/10/20 |
19/10/20 |
Charts
|
5.9K
|
2.3M
|
2
|
|
Charts
|
PER |
Re:
Chart
|
|
bradleyr
|
5.9K |
2.3M |
0 |
19/10/20 |
19/10/20 |
Charts
|
5.9K
|
2.3M
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Grants RPDD to ATL1102 for the treatment of DMD
|
|
bradleyr
|
109 |
29K |
4 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
109
|
29K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Platform trials for DMD..
|
|
bradleyr
|
21 |
6.4K |
6 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
21
|
6.4K
|
6
|
|
ASX - By Stock
|
ZNO |
Re:
ZOONO $4 Party
|
|
bradleyr
|
52 |
16K |
13 |
12/09/20 |
12/09/20 |
ASX - By Stock
|
52
|
16K
|
13
|
|
ASX - By Stock
|
ALC |
Re:
General Discussion / Social Media
|
|
bradleyr
|
6.2K |
3.7M |
6 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
6.2K
|
3.7M
|
6
|
|
ASX - By Stock
|
ZNO |
Re:
Ann: Zoono Announces Full Year Results and Maiden Dividend
|
|
bradleyr
|
189 |
49K |
7 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
189
|
49K
|
7
|
|
ASX - By Stock
|
ZNO |
Re:
Zoono Order Numbers
|
|
bradleyr
|
212 |
63K |
5 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
212
|
63K
|
5
|
|
ASX - By Stock
|
ZNO |
DIVIDEND
|
|
bradleyr
|
24 |
9.8K |
12 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
24
|
9.8K
|
12
|
|
ASX - By Stock
|
ALC |
Re:
chart & chat
|
|
bradleyr
|
2.2K |
4.1M |
3 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
2.2K
|
4.1M
|
3
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Alcidion appointed to NHS Communications Framework
|
|
bradleyr
|
17 |
7.4K |
0 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
17
|
7.4K
|
0
|
|
ASX - By Stock
|
ZNO |
Re:
Long acting claims TGA
|
|
bradleyr
|
12 |
4.7K |
12 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
12
|
4.7K
|
12
|
|
ASX - By Stock
|
ZNO |
Re:
Chart
|
|
bradleyr
|
7.5K |
12M |
3 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
7.5K
|
12M
|
3
|
|
Charts
|
ALC |
Re:
ALC Chart
|
|
bradleyr
|
4.7K |
2.1M |
1 |
24/12/19 |
24/12/19 |
Charts
|
4.7K
|
2.1M
|
1
|
|
Charts
|
ALC |
Re:
ALC Chart
|
|
bradleyr
|
4.7K |
2.1M |
1 |
30/11/19 |
30/11/19 |
Charts
|
4.7K
|
2.1M
|
1
|
|
ASX - By Stock
|
VHT |
Re:
Long Term Bullish - Short Term Not
|
|
bradleyr
|
68 |
40K |
5 |
22/10/19 |
22/10/19 |
ASX - By Stock
|
68
|
40K
|
5
|
|
ASX - By Stock
|
VHT |
Re:
Long Term Bullish - Short Term Not
|
|
bradleyr
|
68 |
40K |
5 |
22/10/19 |
22/10/19 |
ASX - By Stock
|
68
|
40K
|
5
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Quarterly Results & Investor Conference Call Details
|
|
bradleyr
|
45 |
28K |
3 |
23/07/19 |
23/07/19 |
ASX - By Stock
|
45
|
28K
|
3
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Chinapayments.com Transactions Update
|
|
bradleyr
|
13 |
5.7K |
3 |
18/02/19 |
18/02/19 |
ASX - By Stock
|
13
|
5.7K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Latest update from Leslie
|
|
bradleyr
|
26 |
10K |
8 |
19/12/18 |
19/12/18 |
ASX - By Stock
|
26
|
10K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial
|
|
bradleyr
|
208 |
89K |
8 |
19/11/18 |
19/11/18 |
ASX - By Stock
|
208
|
89K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial
|
|
bradleyr
|
208 |
89K |
8 |
19/11/18 |
19/11/18 |
ASX - By Stock
|
208
|
89K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial
|
|
bradleyr
|
208 |
89K |
4 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
208
|
89K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study
|
|
bradleyr
|
369 |
182K |
0 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
369
|
182K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension
|
|
bradleyr
|
490 |
244K |
4 |
24/10/18 |
24/10/18 |
ASX - By Stock
|
490
|
244K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
voluntary Suspension
|
|
bradleyr
|
21 |
9.5K |
3 |
24/10/18 |
24/10/18 |
ASX - By Stock
|
21
|
9.5K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
voluntary Suspension
|
|
bradleyr
|
21 |
9.5K |
2 |
24/10/18 |
24/10/18 |
ASX - By Stock
|
21
|
9.5K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Phase 1b trial end and results
|
|
bradleyr
|
24 |
11K |
7 |
22/10/18 |
22/10/18 |
ASX - By Stock
|
24
|
11K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
bradleyr
|
137 |
78K |
7 |
09/10/18 |
09/10/18 |
ASX - By Stock
|
137
|
78K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Hint of events to follow
|
|
bradleyr
|
141 |
62K |
11 |
10/07/18 |
10/07/18 |
ASX - By Stock
|
141
|
62K
|
11
|
|
ASX - By Stock
|
LNU |
Re:
Ann: Warner Bros. and Linius sign collaboration agreement
|
|
bradleyr
|
257 |
106K |
2 |
08/02/18 |
08/02/18 |
ASX - By Stock
|
257
|
106K
|
2
|
|